ANNA LEACH: Open Payments
NPI 1073367751 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,512 in 109 payments from 40 companies in 2025. Trend: 2023 $0 · 2024 $1,564 · 2025 $2,512
Food & beverage: $2,422Education: $90
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $269 |
| E.R. Squibb & Sons, L.L.C. | 12 | $218 |
| Novartis Pharmaceuticals Corporation | 12 | $196 |
| Merck Sharp & Dohme LLC | 8 | $191 |
| GENZYME CORPORATION | 6 | $147 |
| Janssen Biotech, Inc. | 6 | $145 |
| Gilead Sciences, Inc. | 1 | $111 |
| Genentech USA, Inc. | 5 | $99 |
| Astellas Pharma US Inc | 4 | $93 |
| BeOne Medicines USA, Inc. | 4 | $93 |
Products named: KEYTRUDA, OPDIVO, KISQALI, Trodelvy, REBLOZYL, ENHERTU, AYVAKIT, ERLEADA.
Industry payments across TN — which companies pay providers there.
